Keyphrases
Polymorphism
100%
TP53 Gene
100%
MDM2 Gene
100%
Therapy-related Myeloid Neoplasms
100%
Apoptosis
33%
DNA Repair
33%
Jurkat
33%
Cell Cycle Arrest
33%
MDM2 SNP309
33%
Cancer Therapy
16%
Chromosomal Abnormalities
16%
Severe Complications
16%
Genetic Variation
16%
Biological Effects
16%
Inductors
16%
Association Study
16%
DNA Damage
16%
Attenuation
16%
Apoptotic Potential
16%
P53 Pathway
16%
Disrepair
16%
Apoptotic Response
16%
DNA Lesions
16%
Isogenic Cell Lines
16%
Tumor Protein p53 (TP53)
16%
P53 Codon 72
16%
TP53 Polymorphism
16%
Chemotherapy Agents
16%
Medicine and Dentistry
Neoplasm
100%
Programmed Cell Death
33%
DNA Repair
33%
DNA Damage
33%
Protein P53
33%
Cell Cycle Arrest
33%
Cell Cycle Checkpoint
33%
Allele
33%
Chromosome Aberration
16%
Cancer Therapy
16%
Biological Activity
16%
Chemotherapy Agent
16%
Genetic Variation
16%
Cell Line
16%
Arginine
16%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Cell Cycle Checkpoint
33%
DNA Repair
33%
DNA Damage
33%
P53
33%
Allele
33%
Cell Cycle Arrest
33%
Chromosomal Abnormalities
16%
Genetic Divergence
16%
Biological Activity
16%
Genetic Variation
16%
Arginine
16%
Immunology and Microbiology
Myeloid
100%
P53
33%
DNA Repair
33%
DNA Damage
33%
Allele
33%
Cell Cycle Arrest
33%
Cell Cycle Checkpoint
33%
Cell Line
16%
Genetic Variation
16%
Biological Activity
16%
Agricultural and Biological Sciences
Myeloid
100%
Allele
33%
Programmed Cell Death
33%
DNA Repair
33%
DNA Damage
33%
Cell Cycle Checkpoint
33%
Cell Line
16%
Arginine
16%
Genetic Divergence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Protein P53
33%
Chemotherapy Agent
16%
Malignant Neoplasm
16%
Chromosome Aberration
16%
Arginine
16%